Localized NNR spectroscopy (MRS) of observable brain proton (1H) metabolites levels is currently used in many centers for non-invasive studies of tumors, stroke, HIV infection, multiple sclerosis, and Alzheimer' disease. To cover a significant portion of the brain; current 1H MRS techniques interleave 2-D slices, each measured separately by a spin-echo sequence. Unfortunately, interleaving is an inefficient use of the limited clinical examination time, and the spin-echo delays cause T1-weighting and J-coupling modulations of the signals. Consequently the observed metabolite levels depend on the particular localization scheme used and the sensitivity is relatively low considering that the variation in these pathologies are less than 30 percent. The applicants proposed to address the issues of low sensitivity and sequence-dependence by developing 3-D localization methods using combinations (hybrids) of two non-echo, multivoxel 1H MRS techniques: Chemical Shift Imaging (CSl) with Hadamard Spectroscopic Imaging (HS1). Three significant benefits could be realized. First, per equal measurement time, 3-D hybrids will result in a two to three fold gain in sensitivity over 2-D interleaved acquisition (depending on whether 4 or 8 slices are sought). Second, because the hybrids are non-echo, the J- coupling modulation artifacts and T2 losses will be minimal, yielding another 25 to 50 percent of sensitivity. Combined, the overall three to five fold increase will provide a dramatic boost to the reliability of metabolite level evaluation. Third, because the development will result in software to generate optimized pulse sequences, the methods could be implemented on any imager capable of producing shaped pulses. Since expensive, fast shielded-gradients are not intrinsically required, the proposed research will make multivoxel brain 1H MRS accessible to sites not yet equipped with them.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS033385-02
Application #
2416370
Study Section
Special Emphasis Panel (ZRG7-DMG (01))
Program Officer
Jacobs, Tom P
Project Start
1996-07-22
Project End
1999-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Filippi, M; Bozzali, M; Rovaris, M et al. (2003) Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126:433-7
Li, Belinda S Y; Regal, Juleiga; Soher, Brian J et al. (2003) Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 24:68-74
Gonen, Oded; Moriarty, David M; Li, Belinda S Y et al. (2002) Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations. Radiology 225:261-8
Li, Belinda S Y; Babb, James S; Soher, Brian J et al. (2002) Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 47:439-46
Bonneville, Fabrice; Moriarty, David M; Li, Belinda S Y et al. (2002) Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 23:371-5
Li, B S; Regal, J; Gonen, O (2001) SNR versus resolution in 3D 1H MRS of the human brain at high magnetic fields. Magn Reson Med 46:1049-53
Movsas, B; Li, B S; Babb, J S et al. (2001) Quantifying radiation therapy-induced brain injury with whole-brain proton MR spectroscopy: initial observations. Radiology 221:327-31
Gonen, O; Gruber, S; Li, B S et al. (2001) Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol 22:1727-31
Gonen, O; Grossman, R I (2000) The accuracy of whole brain N-acetylaspartate quantification. Magn Reson Imaging 18:1255-8
Gonen, O; Catalaa, I; Babb, J S et al. (2000) Total brain N-acetylaspartate: a new measure of disease load in MS. Neurology 54:15-9

Showing the most recent 10 out of 17 publications